Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
McKinsey
Johnson and Johnson
Mallinckrodt
Harvard Business School

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Heparin sodium - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for heparin sodium and what is the scope of freedom to operate?

Heparin sodium is the generic ingredient in thirty-eight branded drugs marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Akorn, B Braun Medical Inc, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira Inc, Lilly, Mylan Labs Ltd, Nanjing King-friend, Organon Usa Inc, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs Inc, West-ward Pharms Int, Baxter Hlthcare, Mcgaw, B Braun, Pharma Serve Ny, and 3M, and is included in eighty NDAs. Additional information is available in the individual branded drug profile pages.

There are seventy-seven drug master file entries for heparin sodium. Eighteen suppliers are listed for this compound.

Drug Prices for heparin sodium

See drug prices for heparin sodium

Recent Clinical Trials for heparin sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hospital General “Dr. Miguel Silva” de MoreliaPhase 4
NAUSLIFE HEMODIALYSIS CLINICSPhase 4
Universidad Nacional Autonoma de MexicoPhase 4

See all heparin sodium clinical trials

Pharmacology for heparin sodium

US Patents and Regulatory Information for heparin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun Medical Inc HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 208827-001 Nov 19, 2018 RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017007-005 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 203851-002 Nov 30, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
B Braun HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019135-001 Mar 29, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Express Scripts
Mallinckrodt
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.